BSE List Price : ₹191.00

subscription

Category	Times
QIBs	1.01x
HNIs	2.42x
Retail	2.19x
Total : 1.91x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	2	2,000	₹258,000
Retail Maximum	2	2,000	₹258,000
S-HNI Minimum	3	3,000	₹387,000
S-HNI Maximum	7	7,000	₹903,000
B-HNI Minimum	8	8,000	₹1,032,000

About the Company

Since its establishment in 2021, Accretion Nutraveda has been engaged in the manufacturing of Ayurvedic and nutraceutical products in India. The company offers a diverse range of products across multiple dosages and formats, including tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.

Accretion Nutraveda caters to customers within India as well as overseas markets, including Sri Lanka, Singapore, and the USA. The firm integrates traditional Ayurvedic principles with modern scientific research to develop solutions for various health segments, such as liver care, women’s wellness, bone and joint health, cognitive support, and respiratory health. The company operates a 10,763 sq. ft. manufacturing facility in Gujarat, equipped with modern infrastructure and robust quality control systems.

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2023	₹3.07	₹2.78	₹0.28	₹4.06
2024	₹5.20	₹4.28	₹0.82	₹4.64
2025	₹16.06	₹12.87	₹2.61	₹10.86
Sep 2025	₹14.07	₹11.20	₹2.33	₹16.35

Company Promoter

Mr. Mayur Popatlal Sojitra

Mr. Ankurkumar Shantilal Patel

Mr. Paraskumar Vinubhai Parmar

Mr. Hardik Mukundbhai Prajapati

Mr. Harshad Nanubhai Rathod

Mr. Vivek Ashok Kumar Patel

Know before investing

• • Strengths

  Experienced promoters and a skilled management team possessing strong expertise in Ayurvedic and nutraceutical manufacturing.

  A strong emphasis on quality assurance and regulatory compliance, backed by multiple international certifications.

• • Risks

  Operational risks in manufacturing, such as machinery breakdowns, workplace accidents, or natural events that may disrupt production activities.

  Customer concentration risk arising from reliance on a small group of customers that contribute a substantial share of the company’s revenue.

Objects of the Issue & Utilisation of proceeds

Purchase of Machineries for Automation in existing Manufacturing unit.
Purchase of Machineries for New Manufacturing Setup.
Funding working capital requirements of our company.
General Corporate Purpose.

Company  Address

Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/

IPO Registrar

Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: apl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/

IPO Review

Avoid